Carlyle agrees majority investment in MAI Capital at $2.8bn-plus valuation - Private Equity Wire

China is accelerating the commercial rollout of humanoid robots. On March 30 2026, Shanghai‑based AGIBOT announced its 10,000th unit, citing a rapid scale‑up that has turned humanoids from niche research platforms into mass‑produced devices destined for logistics, retail, hospitality and even industrial workflows; the company also highlighted a new “Humanoid Robot and Embodied Intelligence Standard System (2026 Edition)” issued by the Ministry of Industry and Information Technology, which formalizes safety, ethics and technical requirements across six pillars. At the same time, Unitree Robotics disclosed that average prices for its humanoids have collapsed from about $85,000 in 2023 to roughly $25,000 in 2025, a 70 percent drop that is mirrored across the sector, where models now range from $16,000 for low‑cost platforms up to $250,000 for premium systems. In the United States, policymakers are moving to restrict federal procurement of Chinese‑made humanoids through the Humanoid Robotics Oversight and Blocking of Obtainment from Totalitarians Act, while Amazon announced the acquisition of New York‑based Fauna Robotics, a developer of research‑grade humanoids, signaling major tech interest in integrating embodied AI into personal‑robot and last‑mile delivery solutions.